• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Evaluating the Association of Body Mass Index with COVID-19 Severity and Mortality using Japanese Administrative Claims Data

tetano

Editor, Senior Moderator
J Infect Chemother


. 2024 Apr 16:S1341-321X(24)00115-6.
doi: 10.1016/j.jiac.2024.04.007. Online ahead of print. Evaluating the Association of Body Mass Index with COVID-19 Severity and Mortality using Japanese Administrative Claims Data

Waki Imoto[SUP] 1 [/SUP], Yasutaka Ihara[SUP] 2 [/SUP], Takumi Imai[SUP] 3 [/SUP], Mitsuhiro Tamoto[SUP] 4 [/SUP], Tatoi Ibuki[SUP] 5 [/SUP], Koichi Yamada[SUP] 6 [/SUP], Yukihiro Kaneko[SUP] 7 [/SUP], Ayumi Shintani[SUP] 8 [/SUP], Hiroshi Kakeya[SUP] 9 [/SUP]



Affiliations
Abstract

Introduction: Obesity is a risk factor for aggravation of and mortality from coronavirus disease 2019 (COVID-19). We aimed to investigate the relationship between COVID-19 and Body Mass Index (BMI) in the Japanese population.
Methods: We used administrative claims data from an advanced treatment hospital in Japan and extracted data from patients hospitalized for COVID-19. The exposure variable was BMI measured at the time of admission, and the study outcomes were progression to critical illness and death. Analyses were performed for each age group.
Results: Overall, 58,944 patients met the inclusion criteria. The risk of critical illness increased monotonically with higher BMI. In contrast, the relationship between BMI and mortality follows a J-shaped curve; being underweight and obese are risk factors for mortality. When stratified by age, similar trends were observed for both critical illness and mortality.
Conclusion: A higher BMI is a risk factor for the progression of COVID-19 severity, whereas both lower and higher BMIs are risk factors for mortality in the Japanese population.

Keywords: administrative claims database; body mass index; coronavirus disease 2019; obesity.

 
Back
Top Bottom